Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en méxico

Aguilar-Navarro, Sara; Mimenza-Alvarado, Alberto J.; Palacios-García, Alberto A.; Samudio-Cruz, Alejandra; Gutiérrez-Gutiérrez, Lidia; Ávila-Fuñes, José Alberto

doi:10.1016/j.rcp.2017.05.003

Cited by 72 publications

(36 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…What is more, the correlation coefficient between ACE-III total score and MoCA total score was higher than that between ACE-III total score and MMSE score. Our results were in accordance with previous report 21…”

Section: Discussionsupporting

confidence: 94%

“…The present study suggested that both ACE-III and MoCA had acceptable sensitivity and specificity in differentiating MCI from control subjects. In other words, both ACE-III and MoCA were effective in screening for MCI, which confirmed the usefulness of ACE-III and MoCA in previous studies 18,20,21. Compared to ACE-III, MoCA achieved higher sensitivity and lower specificity in the present study.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

<p>Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment</p>

Wang¹,

Zheng²,

Xu³

et al. 2019

NDT

View full text Add to dashboard Cite

ObjectiveThe aim of this study was to validate the reliability of the Chinese version of Addenbrooke’s Cognitive Examination III (ACE-III) for detecting mild cognitive impairment. Furthermore, the present study compares the diagnostic accuracy of ACE-III with that of Montreal Cognitive Assessment (MoCA).MethodsOne hundred and twenty patients with MCI and 136 healthy controls were included in the study. All patients were evaluated by the Chinese version of ACE-III, MoCA and MMSE.ResultsSubjects in the control group showed better performance in ACE-III total score and its subdomain scores than those in the MCI group. There was a significantly positive correlation between ACE-III total score and MoCA score. Meanwhile, there was also a significantly positive correlation between ACE-III total score and MMSE score. For ACE-III total score, a cut-off point of 85 yielded a sensitivity of 97.3% and a specificity of 90.7%. The AUC for ACE-III total score was 0.978. For MoCA, a cut-off point of 23 yielded a sensitivity of 86.5% and a specificity of 97.7%. The AUC for MoCA was 0.961. There were no significant differences in diagnostic accuracy between ACE-III and MoCA.ConclusionThe present findings support that both ACE-III and MoCA are useful for detecting MCI in early stages.

show abstract

Section: Discussionsupporting

confidence: 94%

Section: Discussionsupporting

confidence: 91%

<p>Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment</p>

Wang¹,

Zheng²,

Xu³

et al. 2019

NDT

View full text Add to dashboard Cite

show abstract

“…Scores are interpreted as follows: >26 indicates no dementia, 18-26 mild cognitive impairment, 6-10 moderate dementia and <6 severe dementia. 33…”

Section: General Cognitive Function Assessed By the Montrealmentioning

confidence: 99%

Double-task exercise programmes to strengthen cognitive and vascular health in older adults at risk of cognitive decline: protocol for a randomised clinical trial

et al. 2020

View full text Add to dashboard Cite

IntroductionCognitive and physical declines are frequent causes of disability among older adults (OAs) in Mexico that imposes significant burden on the health system and OAs’ families. Programmes to prevent or delay OAs’ cognitive and physical decline are scarce.Methods and analysisA double-blind randomised clinical trial will be conducted. The study will aim to evaluate two 24-week double-task (aerobic and cognitive) square-stepping exercise programmes for OAs at risk of cognitive decline—one programme with and another without caregiver participation—and to compare these with an aerobic-balance-stretching exercise programme (control group). 300 OAs (100 per group) affiliated with the Mexican Institute of Social Security (IMSS) between 60 and 65 years of age with self-reported cognitive concerns will participate. They will be stratified by education level and randomly allocated to the groups. The intervention will last 24 weeks, and the effect of each programme will be evaluated 12, 24 and 52 weeks after the intervention. Participants’ demographic and clinical characteristics will be collected at baseline. The outcomes will include: (1) general cognitive function; (2) specific cognitive functions; (3) dual-task gait; (4) blood pressure; (5) carotid intima–media thickness; (6) OAs’ health-related quality of life; and (7) caregiver burden. The effects of the interventions on each outcome variable will be examined using a repeated-measures analysis of variance (ANOVA), with study groups as the between-subjects variable and time as the within-subject variable.Ethics and disseminationThe study was approved by the IMSS Ethics and Research Committees (registration number: 2018-785-095). All participants will sign a consent form prior to their participation. The study results will be disseminated to the IMSS authorities, healthcare providers and the research community.Trial registration numberClinicalTrials.gov (NCT04068376).

show abstract

“…Un puntaje de 0-25 se interpreta como probable deterioro cognitivo y un puntaje mayor de 26 se considera normal. 8,9 Se aplicó el cuestionario de discapacidad auditiva para el adulto mayor en su versión en español Hearing Handicap Inventory for the Elderly-Screening. 10 Este instrumento fue validado en 1982 y evalúa el impacto emocional y social de la hipoacusia en los adultos mayores.…”

Section: Materials Y Métodosunclassified

“…Una de las principales virtudes del MocA es que identifica mejores estados preclínicos como el deterioro cognitivo leve, ya que incluye dominios no evaluados por el Mini-Mental como el funcionamiento ejecutivo, la atención y el recuerdo diferido. 9 La discrepancia entre los resultados de ambas pruebas en el grupo control, la atribuimos a que el MocA detecta el deterioro cognitivo leve y de forma más temprana. 19 Hasta el momento no existen tratamientos efectivos que modifiquen el deterioro cognitivo; sin embargo, el retraso de la aparición del deterioro tiene grandes implicaciones positivas tanto en lo individual, en lo colectivo y en la economía.…”

Section: Wwwmedigraphicorgmxunclassified

Hipoacusia y deterioro cognitivo en adultos mayores

Aragón-Torres¹,

Forische²,

Hernández³

et al. 2019

Anales Médicos De La Asociación Médica Del Centro Médico ABC

View full text Add to dashboard Cite

ResumenAntecedentes: Un tercio de los adultos mayores presentan hipoacusia, en México 67% de las personas mayores de 60 años la padecen y en el Reino Unido 50%. Pronto la hipoacusia será una de las enfermedades más frecuentes. Por otra parte, el deterioro cognitivo afecta a millones de personas, ocasionando discapacidad y dependencia. Se ha demostrado que la pérdida auditiva induce cambios en la función y estructura cerebral, acelerando el deterioro cognitivo. Objetivo: Describir la frecuencia de hipoacusia en los adultos mayores mexicanos con y sin diagnóstico de demencia y evaluar su asociación con el deterioro cognitivo. material y métodos: Descripción de casos, adultos mayores de 65 años con Alzheimer, demencia no especificada y demencia, los controles fueron adultos mayores sanos. Pruebas aplicadas: Mini-Mental State Examination, Test de evaluación cognitiva de Montreal, audiometría tonal, Hearing Handicap Inventory for the Elderly-Screening. Análisis de datos: descriptivo, de asociación y cualitativo; identificando promedio, desviación estándar y porcentajes, utilizando SPSS. Prueba estadística: razón de momios. Resultados: Se estudiaron 10 casos y 17 controles. No existe diferencia estadísticamente significativa entre la edad, sexo, escolaridad, grado de educación y ocupación. La mitad de los pacientes con deterioro cognitivo presentaron una hipoacusia moderada a grave. Existe una asociación entre el grado de hipoacusia y el grado de deterioro cognitivo en el MMSE (p = 0.009), a mayor hipoacusia mayor deterioro cognitivo. Conclusiones: La hipoacusia es considerada un factor de riesgo modificable del deterioro cognitivo. En la población estudiada encontramos una alta frecuencia de deterioro cognitivo. Palabras clave: Hipoacusia, déficit cognitivo, presbiacusia, adulto mayor. nivel de evidencia: III AbstrAct background: One third of older people have hearing loss, in Mexico 67% of people over 60 have it, in the United Kingdom 50%. Soon hearing loss will be one of the most frequent diseases. On the other hand, cognitive impairment affects millions of people, causing disability and dependence. It has been shown that hearing loss induces changes in brain function and structure, accelerating cognitive impairment. Objective: Describe the frequency of hearing loss in Mexican older people with and without a diagnosis of dementia and evaluate its association with cognitive impairment. Material and methods: Cases: adults over 65 with Alzheimer's disease, unspecified dementia and dementia. Controls: healthy older people. Tests: Mini-Mental State Examination, Montreal Cognitive Assessment, tonal audiometry, Hearing Handicap Inventory for the Elderly-Screening. Analysis: descriptive, association and qualitative; identifying average, standard deviation and percentages, using Statistical Package for the Social Sciences. Statistical test: odds ratio. results: Ten cases and 17 controls were studied. There is no statistically significant difference between age, sex, schooling, education degree or occupation. Half of the pati...

show abstract

Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en méxico

Cited by 72 publications

References 36 publications

<p>Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment</p>

<p>Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment</p>

Double-task exercise programmes to strengthen cognitive and vascular health in older adults at risk of cognitive decline: protocol for a randomised clinical trial

Hipoacusia y deterioro cognitivo en adultos mayores

Contact Info

Product

Resources

About